EE200200703A - Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm - Google Patents

Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm

Info

Publication number: EE200200703A
Authority: EE; Estonia
Prior art keywords: blocker; cholesterol; beta; necessary; formulation containing
Prior art date: 2000-06-22

Application number

EEP200200703A

Other languages

English (en)

Estonian (et)

Inventor

Berglund G�ran

Wikstrand John

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-22

Filing date

2001-06-15

Publication date

2004-08-16

2001-06-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-08-16 Publication of EE200200703A publication Critical patent/EE200200703A/xx

Links

239000003529 anticholesteremic agent Substances 0.000 title 1
229940127226 anticholesterol agent Drugs 0.000 title 1
239000002876 beta blocker Substances 0.000 title 1
229940097320 beta blocking agent Drugs 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Pyrane Compounds (AREA)
Pyrrole Compounds (AREA)

EEP200200703A 2000-06-22 2001-06-15 Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm EE200200703A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0002354A SE0002354D0 (sv)	2000-06-22	2000-06-22	New formulation
PCT/SE2001/001380 WO2001097751A2 (en)	2000-06-22	2001-06-15	New formulation comprising a betablocker and optionally a cholesterol-lowering agent

Publications (1)

Publication Number	Publication Date
EE200200703A true EE200200703A (et)	2004-08-16

Family

ID=20280209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200703A EE200200703A (et)	2000-06-22	2001-06-15	Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm

Country Status (28)

Country	Link
US (2)	US20030191177A1 (xx)
EP (1)	EP1296716B1 (xx)
JP (1)	JP2003535875A (xx)
KR (1)	KR20030010750A (xx)
CN (1)	CN1437484A (xx)
AR (1)	AR028699A1 (xx)
AT (1)	ATE344675T1 (xx)
AU (1)	AU2001274766A1 (xx)
BG (1)	BG107373A (xx)
BR (1)	BR0111790A (xx)
CA (1)	CA2411100A1 (xx)
CZ (1)	CZ20024181A3 (xx)
DE (1)	DE60124400T2 (xx)
EE (1)	EE200200703A (xx)
ES (1)	ES2274892T3 (xx)
HK (1)	HK1054508A1 (xx)
HU (1)	HUP0302371A3 (xx)
IL (1)	IL153245A0 (xx)
IS (1)	IS6653A (xx)
MX (1)	MXPA02012957A (xx)
NO (1)	NO20026177L (xx)
NZ (1)	NZ523188A (xx)
PL (1)	PL360484A1 (xx)
RU (1)	RU2271802C2 (xx)
SE (1)	SE0002354D0 (xx)
SK (1)	SK18072002A3 (xx)
WO (1)	WO2001097751A2 (xx)
ZA (1)	ZA200209908B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005053683A1 (en) *	2003-11-26	2005-06-16	Duke University	A method of preventing or treating glaucoma
KR100582347B1 (ko) *	2004-12-30	2006-05-22	한미약품 주식회사	3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
KR100836321B1 (ko)	2006-10-31	2008-06-09	현대자동차주식회사	차량용 모니터 장치
US8703178B2 (en) *	2007-03-08	2014-04-22	Nitto Denko Corporation	Percutaneous administration device of bisoprolol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5175187A (en) *	1989-03-06	1992-12-29	Soorianarain Baligadoo	Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) *	1989-03-06	1995-10-03	Baligadoo; Soorianarain	Synergistic compositions of amiodarone and beta blockers
ATE141049T1 (de) *	1991-03-18	1996-08-15	Sepracor Inc	Zubereitung und verfahren enthaltend optisch reines s-metoprolol
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
NO177455C (no) *	1993-06-04	1995-09-20	Gerrit Elmenhorst	Anordning ved apparat for fremstilling av brannslukkende skum
EP0904082A4 (en) *	1996-04-17	2001-09-26	Merck & Co Inc	COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES
SE9602762D0 (sv) *	1996-07-12	1996-07-12	Astra Ab	Carton and blank for forming the same
US5998458A (en) *	1997-06-25	1999-12-07	University Technology Corporation	Method of treating heart failure
GT199800126A (es) *	1997-08-29	2000-01-29		Terapia de combinacion.
AU779264B2 (en) *	1998-12-23	2005-01-13	G.D. Searle Llc	Combinations for cardiovascular indications

2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Application Discontinuation
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Withdrawn
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 EP EP01941409A patent/EP1296716B1/en not_active Expired - Lifetime
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-20 NO NO20026177A patent/NO20026177L/no not_active Application Discontinuation
2003
- 2003-09-22 HK HK03106811.1A patent/HK1054508A1/zh unknown
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20030191177A1 (en)	2003-10-09
AR028699A1 (es)	2003-05-21
CN1437484A (zh)	2003-08-20
CZ20024181A3 (cs)	2003-04-16
CA2411100A1 (en)	2001-12-27
HUP0302371A2 (hu)	2003-11-28
MXPA02012957A (es)	2003-05-15
SE0002354D0 (sv)	2000-06-22
NO20026177D0 (no)	2002-12-20
SK18072002A3 (sk)	2003-08-05
DE60124400T2 (de)	2007-10-31
RU2271802C2 (ru)	2006-03-20
AU2001274766A1 (en)	2002-01-02
BG107373A (bg)	2003-09-30
HUP0302371A3 (en)	2007-03-28
HK1054508A1 (zh)	2003-12-05
NO20026177L (no)	2002-12-20
EP1296716B1 (en)	2006-11-08
NZ523188A (en)	2006-06-30
ATE344675T1 (de)	2006-11-15
KR20030010750A (ko)	2003-02-05
US20060252814A1 (en)	2006-11-09
PL360484A1 (en)	2004-09-06
DE60124400D1 (de)	2006-12-21
IS6653A (is)	2002-12-11
ZA200209908B (en)	2004-03-05
JP2003535875A (ja)	2003-12-02
IL153245A0 (en)	2003-07-06
EP1296716A2 (en)	2003-04-02
BR0111790A (pt)	2003-05-20
ES2274892T3 (es)	2007-06-01
WO2001097751A2 (en)	2001-12-27
WO2001097751A3 (en)	2002-03-28

Publication	Publication Date	Title
EE200000640A (et)	2002-04-15	Uus kasutamine
NO20023616D0 (no)	2002-07-30	Ny anvendelse
NL1016224A1 (nl)	2001-03-22	Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
EP1508561A4 (en)	2006-07-19	BENZOATEDIC ACID 2- (a-HYDROXYPENTYL) ESTER AND ITS MANUFACTURE AND USE
MA26937A1 (fr)	2004-12-20	Nouvelle composition pharmaceutique.
HUP0400202A3 (en)	2004-10-28	Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
EE05475B1 (et)	2011-10-17	Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
NO20034882D0 (no)	2003-10-31	Ikke-line¶re, elektroseismiske undersökelser
IT249353Y1 (it)	2003-04-14	Rete per uso chirurgico.
ID26774A (id)	2001-02-08	Senyawa benzimidazol, pembuatan dan penggunaannya sebagai komposisi farmasi
NO954834D0 (no)	1995-11-28	Lipoprotein-a-senkende middel, kolesterol-senkende middel, samt medikamenter omfattende disse
NO20030304L (no)	2003-03-12	Ny kombinasjon av serotoninagonist (5HT2) og antagonist (5HT6) som farmasoytisk formulering
NO20035121D0 (no)	2003-11-17	Ny anvendelse
IS2212B (is)	2007-02-15	2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyrarramide
EE200200570A (et)	2004-04-15	Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon
DK1149094T3 (da)	2004-08-16	4-(aminoalkoxy)-benzofuraner som N-myristoyltransferase-inhibitorer
NO20013900D0 (no)	2001-08-10	Epotilonderivater, fremgangsmate og anvendelse derav som legemiddel
DE10196021T1 (de)	2003-07-03	Universeller Vermögenswert- und Beziehungsmanager
FI20011424L (fi)	2002-12-30	Tukiaseman resurssien hallinta ja tukiasema
EP1210084A4 (en)	2002-11-13	PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
BR0009853B1 (pt)	2008-11-18	dispositivo de proteÇço de um recipiente, e, recipiente.
EE9700065A (et)	1997-08-15	Uus keemiline ühend, selle valmistamine ja kasutamine ravimina
EE200200703A (et)	2004-08-16	Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm
NO20034524D0 (no)	2003-10-09	5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
FI20012140L (fi)	2002-01-07	Uudet kvaternääriset yhdisteet, niitä sisältävät koostumukset ja niiden käyttöjä